3 Key Trends Shaping the Clinical Trial Supply Chain

Clinical trial supply chains are constantly evolving, with new technologies and regulations impacting the way that clinical trials are conducted. Ahead of the Clinical Trial Supply Forum 2023, we explore 3 key trends that are shaping the way that clinical trials are conducted globally and helping build a resilient and effective clinical trial supply chain. Read the full report here

The 3 trends explored in this report are going to improve patient-centricity and drive the development of new technologies and regulations to ensure a successful clinical trial supply chain. You must be aware of these trends and adapt the clinical trial supply chain strategies accordingly to stay competitive in the industry. 

The Clinical Trial Supply Forum 2023 is offering an unparalleled opportunity to engage directly with clinical trial supply leaders on these key trends as well other core challenges. Join us in Brussels this May to collaborate, problem solve, and benchmark solutions being implemented right now across the clinical trial supply chain.

We hope you enjoyed reading the 3 key trends report and we hope to see you in May to discuss other core challenges at Clinical Trial Supply Forum 2023. If you have any questions contacts us [email protected]

Clinical Trial Supply Forum

Pharma IQ

%7Babf10f6f 3787 418e 8204 5a9decc138cb%7D CTS logo

IQPC Ltd: 129 Wilton Road, London, SW1V 1JZ, United Kingdom.

You may be receiving this email for a number of reasons:  from our research we have identified you to have an interest in the content of this communication; you may have expressed a previous interest in the topic addressed in this communication; you have participated in an IQPC event or we have had some previous connection, correspondence or relationship.   If you�re a resident of Canada: You are receiving this because you opted in or attended an IQPC event.

We respect your right to privacy. Read our privacy policy.

Stay in control and manage your contact preferences, or unsubscribe from direct marketing.